clinical trial recruiting: MD Anderson - Evaluation of Robot-Assisted Surgery in Gynecologic Oncology - Full Text View - ClinicalTrials.gov

Evaluation of Robot-Assisted Surgery in Gynecologic Oncology - Full Text View - ClinicalTrials.gov

Cervical Cancer Screening: VICC Explains Changes in Recommended Guidelines : Vanderbilt-Ingram Cancer Center

J Altern Complement Med. 2009 A Systematic Review of the Therapeutic Effects of Reiki

Association of rare MSH6 variants with familial breast cancer.

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: GOG

Ovarian cancer -- Easily Missed?-- BMJ

U.K.....This equates to about one new diagnosis for each full time general practitioner every five years

The role of cancer stem cells and the side population in epithelial ovarian cancer

click on 'pdf' for access to the free full access document

Federal PreBudget Consult: Planning for Investments in Support of the Seriously‐ill and Dying as a Public Policy Response to Sustaining Canadian ...

Planning for Investments in Support of the Seriously‐ill and Dying as a Public Policy Response to Sustaining Canadian Productivity, Economic Competitiveness and Quality‐of‐Living

video re: OVA1 test "Doctor Makes Ovarian Cancer Breakthrough"

Doctor Makes Ovarian Cancer Breakthrough | MyFox Memphis | Fox 13 News

Gynecologic Oncology : Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI

ScienceDirect - Gynecologic Oncology : Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI

European Journal of Cancer : Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls

Gynecologic Oncology : The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer

Extraordinary Measures - movie New Film Tells the Story of Rare Disease Advocacy

Extraordinary Measures // home

Conference Jan 2010: Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories, and Clinical Data Workshop

Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories, and Clinical Data Workshop

NIH Office of Rare Diseases Research (ORDR) - Scientific Conferences

December 10, 2009 - December 11, 2009

NIH Office of Rare Diseases Research (ORDR) - Scientific Conferences

NORD Rare Disease Support Community - Inspire

NORD Rare Disease Support Community - Inspire

Rare Cancers with High Mortality Rates: Partnering for Cures - Program Schedule and Sessions Dec 1-3 New York

Partnering for Cures - Program Schedule and Sessions

Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology

Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology

Making sense of the new breast cancer guidelines (and cervical cancer commentary) - news item

Making sense of the new breast cancer guidelines

Call for Clarity in the Reporting of Benefit Associated With Anticancer Therapies -- Booth et al. 27 (33): e213 -- Journal of Clinical Oncology

"disease control rate"

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.

search results: "ovarian cancer" AHRQ

AHRQ National Resource Center:Report on Engaging Consumers in Health

Report on Engaging Consumers in Health IT Development

Why Holidays Don’t Have to Be ‘Happy’

Burned Out, Depressed Surgeons More Likely to Commit More Major Medical Errors

NIH - Ovarian Cancer (numerous sections)

NIH - Ovarian Cancer

NCI
National Cancer Institute

* Angiogenesis Inhibitors in the Treatment of Cancer
* Cancer.gov Dictionary
* Etapa del cáncer: preguntas y respuestas Spanish
* Extracranial Germ Cell Tumor (Childhood)
* Genetics of Breast and Ovarian Cancer (PDQ)
* Increased Risk of Ovarian Cancer is Linked to Estrogen Replacement Therapy
* NCI Designated Cancer Centers
* Oral Contraceptives and Cancer Risk
* Ovarian Cancer
* Ovarian Cancer: U.S. Racial/Ethnic Cancer Patterns
* PDQ-Prevention-Patients: Ovarian Cancer
* PDQ-Screening-Patients: Ovarian Cancer
* PDQ-Tratamiento-Pacientes: Cáncer Epitelial de los Ovarios Spanish
* PDQ-Tratamiento-Pacientes: Tumor de células germinales del ovario Spanish
* PDQ-Tratamiento-Pacientes: Tumores del Ovario de Bajo Potencial Maligno Spanish
* PDQ-Treatment-Patients: Ovarian Epithelial Cancer
* PDQ-Treatment-Patients: Ovarian Germ Cell Tumor
* PDQ-Treatment-Patients: Ovarian Low Malignant Potential Tumor
* Preguntas y respuestas acerca del cáncer metastásico Spanish
* Questions and Answers about Metastatic Cancer
* Questions and Answers: OvaCheck and NCI/FDA Ovarian Cancer Clinical Trials Using Proteomics Technology
* SEER Cancer Statistics Review 1973-1999: Ovary Cancer (Invasive) PDF
* Tumor de células germinales del ovario (PDQ®): Tratamiento Spanish
* Tumor Grade
* What You Need To Know About Ovarian Cancer

contact number Call (800) 422-6237 for more information
Related Topics

* Cancers
* Women's Health



Clinical Trials Information
The NIH funds research studies that you may be able to join. Visit clinicaltrials.gov for a list of ongoing clinical trials.
This page was last reviewed on 7/10/2009

Health News Review: Objective Ratings of Health and Medical Journalism

"News of the new recommendations from the US Preventative Services Task Force (USPSTF) stating that average risk women need not start regular mammography screening until age 50 has exploded all over the media......"

Introducing new molecular technologies into routine clinical cancer care. What new technology and what for?

HealthPolicyMonitor Surveys| CPRN - Canada| 09| Canadian Partnership Against Cancer

Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma